demonstrated that A2BR-deficient mice exhibited slower tumor growth and a higher frequency of total tumor-infiltrating CD8+ T cells and tumor antigen-specific CD8+ T cells than wild-type mice. The gene discussed is CD8A; the disease is neoplasm.